Report cover image

Phosphate Rock Market

Published Jan 20, 2026
Length 100 Pages
SKU # GV20873223

Description

Phosphate Rock Market Summary

The global phosphate rock market size was estimated at USD 35.11 billion in 2025 and is projected to reach USD 54.38 billion by 2033, growing at a CAGR of 5.8% from 2026 to 2033. The market growth is primarily propelled by the non-negotiable demand for phosphorus in feeding a growing world population.

Phosphate-based fertilizers are a critical component of modern agriculture, with mineral fertilizers as a whole responsible for an estimated 50% of global crop yields. This creates immense, inelastic demand, particularly in large agricultural economies. For instance, China, the world's largest producer, mined approximately 110 million metric tons of phosphate rock in 2024 to support its domestic food security and fertilizer industry. Similarly, major importers like India consume around 9-10 million tons of phosphate fertilizers (expressed as P₂O₅) annually, relying on consistent raw material imports to sustain yields for its vast population.

Geopolitical and production concentration critically shape market stability and investment. The phosphate rock industry is defined by extreme reserve concentration, with Morocco, China, the U.S., and Russia collectively controlling approximately 84% of global phosphate rock reserves according to the U.S. Geological Survey. This creates supply chain vulnerability, as seen when China imposed steep export tariffs in 2021, causing immediate global price spikes. In response, new production is coming online in other regions to diversify supply; for example, Saudi Arabia's major Ma'aden Wa'ad Al Shamal project is designed to process up to 16 million tons of ore annually, producing about 3 million tons of finished phosphate fertilizers.

Technological advancements are essential drivers for maintaining supply from lower-grade deposits and meeting environmental standards. As high-grade reserves are depleted, modern beneficiation techniques are crucial. In advanced operations, flotation and other methods can achieve phosphate recovery rates of 85-95% from mined ore. Environmental regulations also directly influence production geography and methods. In Florida, a historic production hub, annual output has declined from a peak of over 40 million tons in 1980 to recent levels of 18-20 million tons, partly due to stricter regulations, pushing capital investment toward large-scale, efficient operations in regions like Morocco's massive mining complex.

Global Phosphate Rock Market Report Segmentation

This report forecasts revenue and volume growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global phosphate rock market report based on end use, and region:
  • End Use Outlook (Volume, Million Tons; Revenue, USD Billion, 2021 - 2033)
  • Fertilizers
  • Food Additives
  • Feed Additives
  • Pharmaceuticals
  • Electronics
  • Chemicals
  • Metal Parts
  • Others
  • Regional Outlook (Volume, Million Tons; Revenue, USD Billion, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • Russia
  • France
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • Egypt
  • Morocco
  • South Africa
  • Tunisia
  • Jordan
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Type
1.2.3. Application
1.2.4. Method
1.2.5. End use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Nucleic Acid Isolation And Purification Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of cancer, genetic disorders, and infectious diseases
3.2.1.2. Increase in public-private funding for biotechnology and life science research
3.2.1.3. Advancements in automation
3.2.1.4. Growth in NGS technologies
3.2.1.5. Growing demand for genetically modified crops and organisms
3.2.2. Market restraint analysis
3.2.2.1. Expensive instruments and consequent low penetration in emerging countries
3.2.2.2. Challenges related to the use of big data and bioinformatics
3.3. Industry Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. Segment Dashboard
4.2. Nucleic Acid Isolation and Purification Market: Product Movement Analysis
4.3. Kits & Reagents
4.3.1. Kits & reagents market estimates and forecasts 2021 - 2033 (USD Million)
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2021 - 2033 (USD Million)
4.4.2. Manual
4.4.2.1. Manual market estimates and forecasts 2021 - 2033 (USD Million)
4.4.3. Automatic
4.4.3.1. Automatic market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 5. Type Business Analysis
5.1. Segment Dashboard
5.2. Nucleic Acid Isolation and Purification Market: Type Movement Analysis
5.3. DNA Isolation & Purification
5.3.1. DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.3.2. Genomic DNA Isolation & Purification
5.3.2.1. Genomic DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.3.3. Plasmid DNA Isolation & Purification
5.3.3.1. Plasmid DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.3.4. Viral DNA Isolation & Purification
5.3.4.1. Viral DNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.3.5. Other
5.3.5.1. Other market estimates and forecasts 2021 - 2033 (USD Million)
5.4. RNA Isolation & Purification
5.4.1. RNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.4.2. miRNA Isolation & Purification
5.4.2.1. miRNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.4.3. mRNA Isolation & Purification
5.4.3.1. mRNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.4.4. Total RNA Isolation & Purification
5.4.4.1. Total RNA isolation & purification market estimates and forecasts 2021 - 2033 (USD Million)
5.4.5. Other
5.4.5.1. Other market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. Segment Dashboard
6.2. Nucleic Acid Isolation and Purification Market: Application Movement Analysis
6.3. Precision Medicine
6.3.1. Precision medicine market estimates and forecasts 2021 - 2033 (USD Million)
6.4. Diagnostics
6.4.1. Diagnostics market estimates and forecasts 2021 - 2033 (USD Million)
6.5. Drug Discovery & Development
6.5.1. Drug discovery & development market estimates and forecasts 2021 - 2033 (USD Million)
6.6. Agriculture and Animal Research
6.6.1. Agriculture and animal research market estimates and forecasts 2021 - 2033 (USD Million)
6.7. Other Applications
6.7.1. Other applications market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 7. Method Business Analysis
7.1. Segment Dashboard
7.2. Nucleic Acid Isolation and Purification Market: Method Movement Analysis
7.3. Column Based
7.3.1. Column based medicine market estimates and forecasts 2021 - 2033 (USD Million)
7.4. Magnetic Beads
7.4.1. Magnetic beads market estimates and forecasts 2021 - 2033 (USD Million)
7.5. Reagent Based
7.5.1. Reagent based market estimates and forecasts 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 8. End Use Business Analysis
8.1. Segment Dashboard
8.2. Nucleic Acid Isolation and Purification Market: End Use Movement Analysis
8.3. Academic Research Institutes
8.3.1. Academic research institutes market estimates and forecasts 2021 - 2033 (USD million)
8.4. Pharmaceutical and Biotechnology Companies
8.4.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2021 - 2033 (USD Million)
8.5. Contract Research Organizations
8.5.1. Contract research organizations market estimates and forecasts 2021 - 2033 (USD Million)
8.6. Hospitals and Diagnostic Centers
8.6.1. Hospitals and diagnostic centers market estimates and forecasts 2021 - 2033 (USD Million)
8.7. Other End-use
8.7.1. Other end-use market estimates and forecasts 2021 - 2033 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2. U.S.
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3. Canada
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
9.4.4. Mexico
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Europe
9.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
9.5.2. UK
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
9.5.3. Germany
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
9.5.4. France
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
9.5.5. Italy
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
9.5.6. Spain
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
9.5.7. Norway
9.5.7.1. Key country dynamics
9.5.7.2. Competitive scenario
9.5.7.3. Regulatory framework
9.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
9.5.8. Sweden
9.5.8.1. Key country dynamics
9.5.8.2. Competitive scenario
9.5.8.3. Regulatory framework
9.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
9.5.9. Denmark
9.5.9.1. Key country dynamics
9.5.9.2. Competitive scenario
9.5.9.3. Regulatory framework
9.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Asia Pacific
9.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
9.6.2. Japan
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
9.6.3. China
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
9.6.4. India
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. Regulatory framework
9.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
9.6.5. Australia
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Regulatory framework
9.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
9.6.6. South Korea
9.6.6.1. Key country dynamics
9.6.6.2. Competitive scenario
9.6.6.3. Regulatory framework
9.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
9.6.7. Thailand
9.6.7.1. Key country dynamics
9.6.7.2. Competitive scenario
9.6.7.3. Regulatory framework
9.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.7. Latin America
9.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
9.7.2. Brazil
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
9.7.3. Argentina
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.8. MEA
9.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
9.8.2. South Africa
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory framework
9.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
9.8.3. Saudi Arabia
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory framework
9.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.8.4. UAE
9.8.4.1. Key country dynamics
9.8.4.2. Competitive scenario
9.8.4.3. Regulatory framework
9.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.8.5. Kuwait
9.8.5.1. Key country dynamics
9.8.5.2. Competitive scenario
9.8.5.3. Regulatory framework
9.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2025
10.4. Company Profiles/Listing
10.4.1. QIAGEN
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Thermo Fisher Scientific, Inc.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Illumina, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Danaher
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. F. Hoffmann-La Roche Ltd
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Merck KGaA
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Agilent Technologies
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Bio-Rad Laboratories, Inc.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Takara Bio Inc.
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Promega Corporation
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.